Blog

Veli Bakalov: My first investigator-initiated clinical trial is now open for enrollment

Veli Bakalov/X

Dec 9, 2024, 14:35

Veli Bakalov: My first investigator-initiated clinical trial is now open for enrollment

Veli Bakalov, Oncologist at MD Anderson Cancer center at Cooper University Health Care and Author of HemeOncBuddy app, shared a post on X:

“Announcement.

My first investigator-initiated clinical trial, INSPIRE-CRT, is now open for enrollment at MD Anderson Cancer Center at Cooper University Health Care.

We are studying if incentive spirometry can reduce pneumonitis rates, severity, and hospitalizations in lung cancer patients undergoing chemoradiation and maintenance treatment (ICI or TKI).

Your support matters.

If interested in opening this trial at your site, please DM for details.

Together, let’s improve outcomes and quality of life for lung cancer patients.”

Veli Bakalov

For more updates, follow OncoDaily.

cancer Cancer Center chemoradiation Cooper University Health Care health health care INSPIRE-CRT Lung cancer lung cancer patients MD Anderson Cancer Center OncoDaily Oncology patients pneumonitis spirometry Veli Bakalov

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%

Stanley Tucci and Throat Cancer: How He Went Against, How He Survived, and More

Senator John Fetterman Responds to OncoDaily on Pediatric Oncology Funding